CIK 0001875558
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Nuvectis Pharma, Inc.
Sign in to watch- Ticker
- NVCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 862405608
- Phone
- +1 360-837-7232
- Business address
- 1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ, 07024
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-14 | BENTSUR RON Chairman & CEO | Purchase | +8,000 | $5.88 | $47K | 2,814,459 |
| 2022-02-10 | BENTSUR RON Chairman & CEO | Purchase | +8,500 | $6.34 | $54K | 2,806,459 |
| 2022-02-07 | Poradosu Enrique Chief Science & Business Off | Purchase | +800 | $3.88 | $3K | 1,197,649 |
| 2022-02-07 | Shemesh Shay Chief Development Officer | Purchase | +846 | $3.47 | $3K | 1,179,615 |
| 2022-02-07 | BENTSUR RON Chairman & CEO | Purchase | +14,000 | $3.93 | $55K | 2,791,959 |
| 2022-02-07 | BENTSUR RON Chairman & CEO | Purchase | +6,000 | $8.25 | $50K | 2,797,959 |
| 2022-02-04 | Poradosu Enrique Chief Science & Business Off | Purchase | +3,800 | $3.35 | $13K | 1,196,849 |
| 2022-02-04 | Shemesh Shay Chief Development Officer | Purchase | +2,100 | $3.38 | $7K | 1,178,769 |
| 2022-02-04 | BENTSUR RON Chairman & CEO | Purchase | +200,000 | $5.00 | $1.0M | 2,765,459 |
| 2022-02-04 | BENTSUR RON Chairman & CEO | Purchase | +12,500 | $3.89 | $49K | 2,777,959 |
Page 10 of 10 · 190 trades